, FNA
--/--/-- --:--:-- Назад к новостям
Дата: | --/--/-- --:--:-- |
Id события: | E5D009DM9 |
Тип действия: | ACQUISITION |
Статус действия: | ANNOUNCED |
Символ покупателя: | |
Целевой символ: | FNA |
Обновлено: | --/--/-- --:--:-- |
Цена покупки за акцию: | 13 |
Цена за акцию в валюте: | USD |
Ссылки на новости: | https://www.sec.gov/Archives/edgar/data/1531978/000114036125009097/ny20044078x2_defm14a.htm |
Action Notes
Zimmer Biomet Holdings (Zimmer) is acquiring all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. Closing of the proposed transaction is subject to receipt of required regulatory approvals, approval by Paragon 28 stockholders and other customary closing conditions, and is anticipated to close in the first half of 2025. on 03/11, it was announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired. The Paragon special shareholder meeting to vote on the transaction will be held on 04/17.